Factors influencing uptake of familial long QT syndrome genetic testing
- 6 November 2015
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 170 (2), 418-425
- https://doi.org/10.1002/ajmg.a.37455
Abstract
Ongoing challenges of clinical assessment of long QT syndrome (LQTS) highlight the importance of genetic testing in the diagnosis of asymptomatic at-risk family members. Effective access, uptake, and communication of genetic testing are critical for comprehensive cascade family screening and prevention of disease complications such as sudden cardiac death. The aim of this study was to describe factors influencing uptake of LQTS genetic testing, including those relating to access and family communication. We show those who access genetic testing are overrepresented by the socioeconomically advantaged, and that although overall family communication is good, there are some important barriers to be addressed. There were 75 participants (aged 18 years or more, with a clinical and/or genetic diagnosis of LQTS; response rate 71%) who completed a survey including a number of validated scales; demographics; and questions about access, uptake, and communication. Mean age of participants was 46 ± 16 years, 20 (27%) were males and 60 (80%) had genetic testing with a causative gene mutation in 42 (70%). Overall uptake of cascade testing within families was 60% after 4 years from proband genetic diagnosis. All participants reported at least one first-degree relative had been informed of their risk, whereas six (10%) reported at least one first-degree relative had not been informed. Those who were anxious or depressed were more likely to perceive barriers to communicating. Genetic testing is a key aspect of care in LQTS families and intervention strategies that aim to improve equity in access and facilitate effective family communication are needed.Keywords
This publication has 43 references indexed in Scilit:
- Cascade Screening in Families with Inherited Cardiac Diseases Driven by Cardiologists: Feasibility and Nationwide Outcome in Long QT SyndromeCardiology, 2013
- HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)Heart Rhythm, 2011
- Risk for Life-Threatening Cardiac Events in Patients With Genotype-Confirmed Long-QT Syndrome and Normal-Range Corrected QT IntervalsJournal of the American College of Cardiology, 2011
- Health status in patients at risk of inherited arrhythmias and sudden unexpected death compared to the general populationBMC Medical Genetics, 2010
- Is inequity undermining Australia's ‘universal’ health care system? Socio‐economic inequalities in the use of specialist medical and non‐medical ambulatory health careAustralian and New Zealand Journal of Public Health, 2009
- Misdiagnosis of Long QT Syndrome as Epilepsy at First PresentationAnnals of Emergency Medicine, 2009
- Factors Determining Dissemination of Results and Uptake of Genetic Testing in Families with Known BRCA1/2 MutationsGenetic Testing, 2008
- Tolerance for uncertainty and perceived risk among women receiving uninformativeBRCA1/2test resultsSeminars in Medical Genetics, Part C of the American Journal of Medical Genetics, 2006
- High Distress in Parents Whose Children Undergo Predictive Testing for Long QT SyndromePublic Health Genomics, 2005
- Predictive genetic testing for hereditary non-polyposis colorectal cancer: Uptake and long-term satisfactionInternational Journal of Cancer, 2000